Modern agriculture faces mounting challenges from climate change, soil degradation, and rising biotic and abiotic stresses, ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...
CRISPR Therapeutics (SRSP) stock gains as the company gets a new Overweight rating from J.P. Morgan thanks to its therapeutic ...
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback